Abstract
The ductus arteriosus is a muscular artery connecting two elastic arteries with different resistances. It is a normal fetal structure that only becomes pathological if it remains patent after birth. A varied clinical impact is observed as some neonates may be asymptomatic, symptoms may be deferred until later in life, or the infant may be overtly symptomatic and present as early as the first days of life. Prematurity increases the likelihood of persistent ductal patency and is seen in about 30% of preterm infants. In premature neonates, patent ductus arteriosus (PDA) is associated with significant morbidity and mortality [1,2]. This discussion explains the pathophysiology behind the pathological events associated with PDA.
Keywords: Patent ductus arteriosus, extremely premature neonate, pathophysiology, pulmonary blood flow.
Current Pediatric Reviews
Title:Pathophysiology of Patent Ductus Arteriosus in the Preterm Infant
Volume: 12 Issue: 2
Author(s): Joseph J. Vettukattil
Affiliation:
Keywords: Patent ductus arteriosus, extremely premature neonate, pathophysiology, pulmonary blood flow.
Abstract: The ductus arteriosus is a muscular artery connecting two elastic arteries with different resistances. It is a normal fetal structure that only becomes pathological if it remains patent after birth. A varied clinical impact is observed as some neonates may be asymptomatic, symptoms may be deferred until later in life, or the infant may be overtly symptomatic and present as early as the first days of life. Prematurity increases the likelihood of persistent ductal patency and is seen in about 30% of preterm infants. In premature neonates, patent ductus arteriosus (PDA) is associated with significant morbidity and mortality [1,2]. This discussion explains the pathophysiology behind the pathological events associated with PDA.
Export Options
About this article
Cite this article as:
J. Vettukattil Joseph, Pathophysiology of Patent Ductus Arteriosus in the Preterm Infant, Current Pediatric Reviews 2016; 12 (2) . https://dx.doi.org/10.2174/157339631202160506002215
DOI https://dx.doi.org/10.2174/157339631202160506002215 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypertension in Patients with Severe Aortic Stenosis: Emphasis on Antihypertensive Treatment and the Risk of Syncope
Current Hypertension Reviews Conduction Disorders: The Value of Surface ECG
Current Cardiology Reviews Further Issues with New Oral Anticoagulants
Current Pharmaceutical Design Use of Clinically Available PPAR Agonists for Heart Failure; Do the Risks Outweigh the Potential Benefits?
Current Molecular Pharmacology Bayes Syndrome and Imaging Techniques
Current Cardiology Reviews Effect of Flavonoids on Human Health: Old Subjects but New Challenges
Recent Patents on Biotechnology The Critical Role of Toll-Like Receptor Signaling Pathways in the Induction and Progression of Autoimmune Diseases
Current Molecular Medicine Antivitamin K Drugs in Stroke Prevention
Current Vascular Pharmacology The Evil Axis of Obesity, Inflammation and Type-2 Diabetes
Endocrine, Metabolic & Immune Disorders - Drug Targets Plasma Steroid Level Measured Using Modern Separation Techniques as Biomarkers in Biological Diagnostics
Current Pharmaceutical Analysis Targeting miRNAs for Drug Discovery: A New Paradigm
Current Molecular Medicine ABC Transporters and Sterol Absorption
Current Drug Targets - Cardiovascular & Hematological Disorders Bone Disease - Current Knowledge and Future Prospects
Current Genomics Lipid-lowering Drug Therapy in Elderly Patients
Current Pharmaceutical Design Cardioprotective Effects of Natural Products <i>via</i> the Nrf2 Signaling Pathway
Current Vascular Pharmacology The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
Current Cardiology Reviews It’s Time for An Epigenomics Roadmap of Heart Failure
Current Genomics A New Practice: Study on the Molecular Mechanism of Traditional Chinese Medicine by Computational Pharmacology Methods: Part 2: Pharmacodynamic Modeling and Distribution on Ligand-Target Space of Effective Components
Letters in Drug Design & Discovery Osteoprotegerin and Diabetes-Associated Pathologies
Current Molecular Medicine Meet our Editorial Board Member
Cardiovascular & Hematological Agents in Medicinal Chemistry